STLD post-earnings: analysts raise targets as hedges unwind
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Steel Dynamics has cleared its Q3 earnings event and the defensive options positioning that defined the pre-print setup has begun to ease, leaving the stock in a cleaner technical position than it entered.
The options market has unwound notably since the earnings-day peak. The put/call ratio pulled back to 0.62 from the 0.63 reading that marked the most defensive posture in months, and it now sits 1.8 standard deviations above the 20-day mean of 0.57. That is still elevated relative to the recent average, but the direction has changed. Heading into the print, options traders were buying protection even as the stock ground higher. Post-results, Q3 produced a modest positive reaction: the stock gained 1.6% on the day of the release. The stock closed at $244.37 on Tuesday, up 1.6% on the week and 3.9% on the month, while the borrow market remains completely relaxed. Availability has expanded to 2,157%, meaning roughly twenty-two shares are available to borrow for every one currently shorted, the loosest conditions in the past 30 days and well above the 52-week trough of 1,240% hit on September 30. Borrowing costs have crept up 17% on the week to 0.56%, but at that absolute level they remain negligible. Short interest is 2.6% of the free float, drifting lower through October and generating no signal of fresh bearish conviction.
The analyst community has responded to the print with a pair of target upgrades. Wells Fargo's Timna Tanners raised her target to $271 from $257 this morning while holding an Overweight rating, and Barclays lifted to $285 from $272 on Monday, also maintaining Overweight. The two moves bracket the current price of $244 with meaningful implied upside. JP Morgan is more cautious, sitting at Neutral with a $260 target after trimming its view earlier in the month. The consensus mean target is $273, roughly 12% above where the stock trades. On valuation, the stock runs at a trailing P/E of 12x and an EV/EBITDA of 8.2x, the latter down about 0.6 turns over the past 30 days as earnings have grown into the multiple. Factor scores lean bullish on momentum: EPS momentum ranks in the 87th percentile on a 30-day basis and the 82nd percentile on 90 days, a signal the earnings revision cycle has been running the company's way. The dividend score ranks at the 100th percentile, though the dividend history in the dataset is dated and should not be relied upon for current yield figures.
Retail attention has picked up around the earnings event. The Wikipedia views signal is running at a z-score of 2.1 against the stock's own 90-day history, the highest attention reading in the dataset period. This is a measure of awareness rather than a financial indicator, but it is consistent with a name that just printed results into a rising stock price.
The institutional register is passive and stable. BlackRock, Vanguard entities and State Street together hold roughly a fifth of shares outstanding. FMR added over 3 million shares in the most recent reported quarter, the largest single flow in the holder table. No 13D activist is on the register, and the only insider activity in recent weeks has been small grant-type transactions among directors.
The key question for the next few weeks is whether the JP Morgan-versus-Barclays divide on the price ceiling resolves toward the more constructive view, and how the hot-rolled coil pricing environment tracks through Q4 given the mixed signals from sector peers.
Stocks in this article
See the live data behind this article on ORTEX.
Open STLD on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 19:06
- Data as of
- 21 Oct 2026, 19:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.